Julija Hmeljak

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Cardiac Resynchronization Therapy

Coronavirus Disease

Top Venues

Disease models & mechanisms

This page only lists publications with an associated author ORCID identifier.

Publications

Julija Hmeljak, Kirsty M Hooper
Synergistic modelling of human disease. Disease models & mechanisms 17 (2) (2024)
Julija Hmeljak, Kirsty M Hooper
Synergistic modelling of human disease. Disease models & mechanisms 17 (2) (2024)
Julija Hmeljak, Kirsty M Hooper
Synergistic modelling of human disease. Disease models & mechanisms 17 (2) (2024)
Julija Hmeljak, Kirsty M Hooper
Synergistic modelling of human disease. Disease models & mechanisms 17 (2) (2024)
Julija Hmeljak, Kirsty M Hooper
Synergistic modelling of human disease. Disease models & mechanisms 17 (2) (2024)
Kirsty M Hooper, Julija Hmeljak
Supporting the translation of multiscale research in rare disease. Disease models & mechanisms 16 (9) (2023)
Julija Hmeljak, Kirsty M Hooper
The importance of figures in scientific 'show and tell'. Disease models & mechanisms 16 (11) (2023)
Jeroen Bakkers, Milena Bellin, Julija Hmeljak, Ravi Karra
From mechanisms of heart failure to clinical heart success. Disease models & mechanisms 16 (5) (2023)
Monkol Lek, Julija Hmeljak, Kirsty M Hooper
Genetic variance in human disease - modelling the future of genomic medicine. Disease models & mechanisms 15 (6) (2022)
Maria Isabel Loza, Julija Hmeljak, Chas Bountra, James E Audia, Sohini Chowdhury, Shannon Weiman, Kalpana M Merchant, Maria-Jesus Blanco
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic. Disease models & mechanisms 15 (12) (2022)
Donita C Brady, Julija Hmeljak, Arvin C Dar
Understanding and drugging RAS: 40 years to break the tip of the iceberg. Disease models & mechanisms 15 (2) (2022)
Kirsty M Hooper, Julija Hmeljak
Sharing resources to advance translational research. Disease models & mechanisms 15 (10) (2022)
Maria Isabel Loza, Julija Hmeljak, Chas Bountra, James E Audia, Sohini Chowdhury, Shannon Weiman, Kalpana M Merchant, Maria-Jesus Blanco
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic. Disease models & mechanisms 15 (12) (2022)
Maria Isabel Loza, Julija Hmeljak, Chas Bountra, James E Audia, Sohini Chowdhury, Shannon Weiman, Kalpana M Merchant, Maria-Jesus Blanco
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic. Disease models & mechanisms 15 (12) (2022)
Kirsty Hooper, Julija Hmeljak
Disease Models & Mechanisms helps move heart failure to heart success. Disease models & mechanisms 15 (5) (2022)
Maria Isabel Loza, Julija Hmeljak, Chas Bountra, James E Audia, Sohini Chowdhury, Shannon Weiman, Kalpana M Merchant, Maria-Jesus Blanco
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic. Disease models & mechanisms 15 (12) (2022)
Maria Isabel Loza, Julija Hmeljak, Chas Bountra, James E Audia, Sohini Chowdhury, Shannon Weiman, Kalpana M Merchant, Maria-Jesus Blanco
Collaboration and knowledge integration for successful brain therapeutics - lessons learned from the pandemic. Disease models & mechanisms 15 (12) (2022)
Julija Hmeljak, Esperanza Agullo-Pascual
Celebrating FocalPlane and microscopy in Disease Models & Mechanisms. Disease models & mechanisms 14 (7) (2021)
Roger S Smith, Igor Odintsov, Zebing Liu, Allan Jo-Weng Lui, Takuo Hayashi, Morana Vojnic, Yoshiyuki Suehara, Lukas Delasos, Marissa S Mattar, Julija Hmeljak, Hillary A Ramirez, Melissa Shaw, Gabrielle Bui, Alifiani B Hartono, Eric Gladstone, Siddharth Kunte, Heather Magnan, Inna Khodos, Elisa De Stanchina, Michael P La Quaglia, Jinjuan Yao, Marick Laé, Sean B Lee, Lee Spraggon, Christine A Pratilas, Marc Ladanyi, Romel Somwar
Novel patient-derived models of DSRCT enable validation of ERBB signaling as a potential therapeutic vulnerability. Disease models & mechanisms (2021)
Annabel Nicholson, Julija Hmeljak
Travel grants and how to use them (when there's no travel). Disease models & mechanisms 13 (9) (2020)